GSDME and lung carcinoma: Studies on the lung cancer cell line A549 have revealed that both cisplatin and paclitaxel induce pyroptosis via the caspase-3/GSDME signaling pathway, with cisplatin exhibiting a more pronounced effect than paclitaxel (64, 73, 90).